P-251: Comparative effectiveness of teclistamab versus real-world physician’s choice of therapy for patients with triple-class exposed relapsed/refractory multiple myeloma

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览0
暂无评分
关键词
multiple myeloma,teclistamab,real-world,triple-class
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要